Amgen Inc. (BCBA:AMGN)

Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of ARS 276.14 trillion. The enterprise value is 340.09 trillion.

Market Cap	276.14T
Enterprise Value	340.09T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Nov 21, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	80.72%
Float	537.12M

Valuation Ratios

The trailing PE ratio is 24.67 and the forward PE ratio is 16.25.

PE Ratio	24.67
Forward PE	16.25
PS Ratio	5.18
PB Ratio	21.97
P/TBV Ratio	n/a
P/FCF Ratio	23.49
P/OCF Ratio	19.11
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.17, with an EV/FCF ratio of 28.93.

EV / Earnings	30.39
EV / Sales	6.58
EV / EBITDA	14.17
EV / EBIT	20.33
EV / FCF	28.93

Financial Position

The company has a current ratio of 1.14, with a Debt / Equity ratio of 6.31.

Current Ratio	1.14
Quick Ratio	0.73
Debt / Equity	6.31
Debt / EBITDA	3.20
Debt / FCF	6.74
Interest Coverage	4.32

Financial Efficiency

Return on equity (ROE) is 106.10% and return on invested capital (ROIC) is 18.77%.

Return on Equity (ROE)	106.10%
Return on Assets (ROA)	8.15%
Return on Invested Capital (ROIC)	18.77%
Return on Capital Employed (ROCE)	18.28%
Weighted Average Cost of Capital (WACC)	6.19%
Revenue Per Employee	1.91B
Profits Per Employee	399.71M
Employee Count	28,000
Asset Turnover	0.40
Inventory Turnover	1.62

Taxes

In the past 12 months, Amgen has paid 1.84 trillion in taxes.

Income Tax	1.84T
Effective Tax Rate	14.09%

Stock Price Statistics

The stock price has increased by +58.29% in the last 52 weeks. The beta is 0.45, so Amgen's price volatility has been lower than the market average.

Beta (5Y)	0.45
52-Week Price Change	+58.29%
50-Day Moving Average	17,002.60
200-Day Moving Average	14,030.58
Relative Strength Index (RSI)	64.30
Average Volume (20 Days)	2,277

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	4.74

Income Statement

In the last 12 months, Amgen had revenue of ARS 53.34 trillion and earned 11.19 trillion in profits. Earnings per share was 20,653.42.

Revenue	53.34T
Gross Profit	37.76T
Operating Income	17.27T
Pretax Income	13.03T
Net Income	11.19T
EBITDA	24.77T
EBIT	17.27T
Earnings Per Share (EPS)	20,653.42

Balance Sheet

The company has 13.25 trillion in cash and 79.25 trillion in debt, with a net cash position of -66,002.42 billion.

Cash & Cash Equivalents	13.25T
Total Debt	79.25T
Net Cash	-66,002.42B
Net Cash Per Share	n/a
Equity (Book Value)	12.57T
Book Value Per Share	23,313.95
Working Capital	5.18T

Cash Flow

In the last 12 months, operating cash flow was 14.45 trillion and capital expenditures -2,696.70 billion, giving a free cash flow of 11.76 trillion.

Operating Cash Flow	14.45T
Capital Expenditures	-2,696.70B
Free Cash Flow	11.76T
FCF Per Share	n/a

Margins

Gross margin is 70.78%, with operating and profit margins of 32.37% and 20.98%.

Gross Margin	70.78%
Operating Margin	32.37%
Pretax Margin	24.42%
Profit Margin	20.98%
EBITDA Margin	46.43%
EBIT Margin	32.37%
FCF Margin	22.04%

Dividends & Yields

This stock pays an annual dividend of 253.23, which amounts to a dividend yield of 1.40%.

Dividend Per Share	253.23
Dividend Yield	1.40%
Dividend Growth (YoY)	42.14%
Years of Dividend Growth	15
Payout Ratio	66.14%
Buyback Yield	-0.19%
Shareholder Yield	1.22%
Earnings Yield	4.05%
FCF Yield	4.26%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on January 24, 2024. It was a forward split with a ratio of 3.

Last Split Date	Jan 24, 2024
Split Type	Forward
Split Ratio	3

Scores

Altman Z-Score	n/a
Piotroski F-Score	7